Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Florian P. Reiter
The PI3K Inhibitor Copanlisib Synergizes With Sorafenib to Induce Cell Death in Hepatocellular Carcinoma
Cell Death Discovery
Cancer Research
Molecular Neuroscience
Immunology
Cell Biology
Cellular
Related publications
Combinatorial Screening of the Pi3k Inhibitor Copanlisib in T Cell Lymphomas
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Sorafenib in Hepatocellular Carcinoma
Clinical Medicine. Therapeutics
Selinexor Synergizes With Dexamethasone to Repress mTORC1 Signaling and Induce Multiple Myeloma Cell Death
Oncotarget
Oncology
Copanlisib for Treatment of B-Cell Malignancies: The Development of a PI3K Inhibitor With Considerable Differences to Idelalisib
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Next-Generation Proteasome Inhibitor Oprozomib Synergizes With Modulators of the Unfolded Protein Response to Suppress Hepatocellular Carcinoma
Oncotarget
Oncology
Topotecan Synergizes With CHEK1 (CHK1) Inhibitor to Induce Apoptosis in Ovarian Cancer Cells
BMC Cancer
Cancer Research
Oncology
Genetics
Sorafenib vs Nivolumab in Patients With Hepatocellular Carcinoma
Journal of Liver Research, Disorders & Therapy
Antitumor Effect of Sorafenib and mTOR Inhibitor in Liver Transplantation Recipients With Hepatocellular Carcinoma Recurrence
Liver Transplantation
Hepatology
Transplantation
Surgery
MicroRNA‑223 Promotes Hepatocellular Carcinoma Cell Resistance to Sorafenib by Targeting FBW7
Oncology Reports
Medicine
Cancer Research
Oncology